|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NASTECH PHARMACEUTICAL CO INC, S-2/A, 2000-12-11 |
Next: METROPOLITAN LIFE SEPARATE ACCOUNT E, N-4/A, 2000-12-11 |
EXHIBIT 23.1
The Board of Directors
Nastech Pharmaceutical Company Inc.:
We consent to the use of our report dated February 28, 2000 incorporated herein
by reference and to the reference to our firm under the heading "Experts" in the
prospectus.
KPMG LLP
Melville, New York
December 4, 2000
|
|